Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Lymphoma, Large B-Cell, Diffuse 6Sarcoma 5Sarcoma, Ewing 2Rhabdomyosarcoma 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neoplasms, Germ Cell and Embryonal 2Lymphoma, B-Cell 2Teratoma 1Seminoma 1Sarcoma, Synovial 1Sarcoma, Clear Cell 1Sarcoma, Alveolar Soft Part 1Perivascular Epithelioid Cell Neoplasms 1Osteosarcoma 1Nonseminomatous germ cell tumor 1Neurofibrosarcoma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neuroblastoma 1Nerve Sheath Neoplasms 1Neoplasms 1Malignant mesenchymal tumor 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Lymphoma 1Liposarcoma 1Leukemia, Biphenotypic, Acute 1Leiomyosarcoma 1Ichthyosis, X-Linked 1Hodgkin Disease 1

Interventions

Radiotherapy 1Mesna 1Ifosfamide 1ADI PEG20 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Ichthyosis, X-Linked × Ifosfamide × Clear all
NCT05813327 2026-04-20

Neoadjuvant ADI-PEG 20 + Ifosfamide + Radiotherapy in Soft Tissue Sarcoma

Washington University School of Medicine

Phase 1 Active not recruiting
6 enrolled
Sarcoma

Sarcoma, Ichthyosis, X-Linked

Data powered by HemOnc (CC BY 4.0) Colophon âš¡